pI: 7.26 |
Length (AA): 511 |
MW (Da): 56781 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
NA% percentile | epimastigote, metacyclic. | Smircich P |
Smircich P | Ribosome profiling reveals translation control as a key mechanism generating differential gene expression in Trypanosoma cruzi. |
Ortholog group members (OG5_137810)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G45490 | serine/threonine-protein kinase aurora-3 |
Caenorhabditis elegans | CELE_K07C11.2 | Protein AIR-1 |
Leishmania braziliensis | LbrM.26.2370 | protein kinase, putative |
Leishmania donovani | LdBPK_262460.1 | protein kinase, putative |
Leishmania infantum | LinJ.26.2460 | protein kinase, putative |
Leishmania major | LmjF.26.2440 | protein kinase, putative |
Leishmania mexicana | LmxM.26.2440 | protein kinase, putative |
Oryza sativa | 4334220 | Os03g0765000 |
Trypanosoma brucei gambiense | Tbg972.9.370 | protein kinase, putative |
Trypanosoma brucei | Tb11.v5.0874 | protein kinase, putative |
Trypanosoma brucei | Tb927.9.1670 | Aurora kinase 3, putative |
Trypanosoma congolense | TcIL3000_9_260 | protein kinase, putative |
Trypanosoma cruzi | TcCLB.506715.10 | Aurora kinase 3, putative |
Trypanosoma cruzi | TcCLB.510349.80 | Aurora kinase 3, putative |
Trypanosoma cruzi | TcCLB.504655.30 | protein kinase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_K07C11.2 | Caenorhabditis elegans | embryonic arrest | wormbase |
CELE_K07C11.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_K07C11.2 | Caenorhabditis elegans | sterile | wormbase |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.7
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | Mitogen-activated protein kinase 1 | 358 aa | 24.8% | 315 aa | Compounds | References |
Patiria pectinifera | Cdc2 | 300 aa | 26.1% | 295 aa | Compounds | References |
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 26.6% | 293 aa | Compounds | References |
Rattus norvegicus | Jak1 protein | 210 aa | 22.2% | 180 aa | Compounds | References |
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 25.6% | 297 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 26.2% | 286 aa | Compounds | References |
Rattus norvegicus | Serine/threonine-protein kinase pim-3 | 326 aa | 30.3% | 277 aa | Compounds | References |
Schizosaccharomyces pombe 972h- | Casein kinase II subunit alpha | 332 aa | 23.6% | 313 aa | Compounds | References |